|
1
|
Lemaire V, Tobin FL, Greller LD, Cho CR
and Suva LJ: Modeling the interactions between osteoblast and
osteoclast activities in bone remodeling. J Theor Biol.
229:293–309. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alford AI, Kozloff KM and Hankenson KD:
Extracellular matrix networks in bone remodeling. Int J Biochem
Cell Biol. 65:20–31. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arpornmaeklong P, Brown SE, Wang Z and
Krebsbach PH: Phenotypic characterization, osteoblastic
differentiation and bone regeneration capacity of human embryonic
stem cell-derived mesenchymal stem cells. Stem Cells Dev.
18:955–968. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schmalzigaug R, Phee H, Davidson CE, Weiss
A and Premont RT: Differential expression of the ARF GAP genes GIT1
and GIT2 in mouse tissues. J Histochem Cytochem. 55:1039–1048.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Manabe R, Kovalenko M, Webb DJ and Horwitz
AR: GIT1 functions in a motile, multi-molecular signaling complex
that regulates protrusive activity and cell migration. J Cell Sci.
115:1497–1510. 2002.PubMed/NCBI
|
|
6
|
Menon P, Yin G, Smolock EM, Zuscik MJ, Yan
C and Berk BC: GPCR kinase 2 interacting protein 1 (GIT1) regulates
osteoclast function and bone mass. J Cell Physiol. 225:777–785.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ren Y, Yu L, Fan J, Rui Z, Hua Z, Zhang Z,
Zhang N and Yin G: Phosphorylation of GIT1 tyrosine 321 is required
for association with FAK at focal adhesions and for PDGF-activated
migration of osteoblasts. Mol Cell Biochem. 365:109–118. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hassan MQ, Gordon JA, Beloti MM, Croce CM,
van Wijnen AJ, Stein JL, Stein GS and Lian JB: A network connecting
Runx2, SATB2 and the miR-23a~27a~24-2 cluster regulates the
osteoblast differentiation program. Proc Natl Acad Sci USA.
107:19879–8435. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu R, Li H, Liu W, Yang L, Tan YF and Luo
XH: Targeting miRNAs in osteoblast differentiation and bone
formation. Expert Opin Ther Targets. 14:1109–1120. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kapinas K and Delany AM: MicroRNA
biogenesis and regulation of bone remodeling. Arthritis Res Ther.
13:2202011. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kapinas K, Kessler CB and Delany AM:
miR-29 suppression of osteonectin in osteoblasts: Regulation during
differentiation and by canonical Wnt signaling. J Cell Biochem.
108:216–224. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mizuno Y, Yagi K, Tokuzawa Y,
Kanesaki-Yatsuka Y, Suda T, Katagiri T, Fukuda T, Maruyama M, Okuda
A, Amemiya T, et al: miR-125b inhibits osteoblastic differentiation
by down-regulation of cell proliferation. Biochem Biophys Res
Commun. 368:267–272. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Scott GK, Goga A, Bhaumik D, Berger CE,
Sullivan CS and Benz CC: Coordinate suppression of ERBB2 and ERBB3
by enforced expression of micro-RNA miR-125a or miR-125b. J Biol
Chem. 282:1479–1486. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meister G, Landthaler M, Patkaniowska A,
Dorsett Y, Teng G and Tuschl T: Human Argonaute2 mediates RNA
cleavage targeted by miRNAs and siRNAs. Mol Cell. 15:185–197. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chau JF, Leong WF and Li B: Signaling
pathways governing osteoblast proliferation, differentiation and
function. Histol Histopathol. 24:1593–1606. 2009.PubMed/NCBI
|
|
19
|
Oskowitz AZ, Lu J, Penfornis P, Ylostalo
J, McBride J, Flemington EK, Prockop DJ and Pochampally R: Human
multipotent stromal cells from bone marrow and microRNA: Regulation
of differentiation and leukemia inhibitory factor expression. Proc
Natl Acad Sci USA. 105:18372–7. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu Y, Zhang Y, Yin Q, Xia H and Wang J:
Platelet-derived growth factor promotes osteoblast proliferation by
activating G-protein-coupled receptor kinase interactor-1. Mol Med
Rep. 10:1349–54. 2014.PubMed/NCBI
|
|
21
|
Huang WC, Chan SH, Jang TH, Chang JW, Ko
YC, Yen TC, Chiang SL, Chiang WF, Shieh TY, Liao CT, et al:
miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral
squamous cell carcinoma invasion and metastasis. Cancer Res.
74:751–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chan SH, Huang WC, Chang JW, Chang KJ, Kuo
WH, Wang MY, Lin KY, Uen YH, Hou MF, Lin CM, et al: MicroRNA-149
targets GIT1 to suppress integrin signaling and breast cancer
metastasis. Oncogene. 33:4496–507. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Feng C, Li J, Ruan J and Ding K:
MicroRNA-125a inhibits cell growth by targeting glypican-4.
Glycoconj J. 29:503–11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ninio-Many L, Grossman H, Shomron N,
Chuderland D and Shalgi R: microRNA-125a-3p reduces cell
proliferation and migration by targeting Fyn. J Cell Sci.
126:2867–176. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Svensson D, Gidlöf O, Turczyńska KM,
Erlinge D, Albinsson S and Nilsson BO: Inhibition of microRNA-125a
promotes human endothelial cell proliferation and viability through
an antiapoptotic mechanism. J Vasc Res. 51:239–245. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo X, Wu Y and Hartley RS: MicroRNA-125a
represses cell growth by targeting HuR in breast cancer. RNA Biol.
6:575–583. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang K, Fu J, Zhou W, Li W, Dong S, Yu S,
Hu Z, Wang H and Xie Z: MicroRNA-125b regulates osteogenic
differentiation of mesenchymal stem cells by targeting Cbfβ in
vitro. Biochimie. 102:47–55. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guo LJ, Liao L, Yang L, Li Y and Jiang TJ:
MiR-125a TNF receptor-associated factor 6 to inhibit
osteoclastogenesis. Exp Cell Res. 321:142–152. 2014. View Article : Google Scholar : PubMed/NCBI
|
